The immediate and slow release versions work equally. In people with overactive bladder, transdermal<unk>  decreased the number of incontinence episodes and increased average voided volume. There was no difference between transdermal<unk>  and extended-release oral tolterodine. Tentative evidence supports the use of<unk>  in hyperhidrosis (excessive sweating).
Oxybutynin
Xylometazoline
Acebutolol
Tamsulosin
Oxymetazoline
Hyoscine butylbromide
Tolbutamide
Hydrastine